跳至主要内容
临床试验/NCT04828109
NCT04828109已完成不适用

A Digital Intervention Protocol to Enhance Recovery After Head and Neck Surgery

Oregon Health and Science University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2021年10月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
1
主要终点
Mean daily opioid use

研究概览

简要总结

Postoperative recovery after head and neck surgery is complex, and often requires utilization of narcotic medications. The aim of this study is to evaluate reduction in pain and use of opioid medications through Virtual Reality (VR) and Fitbit wearable activity devices.

详细描述

Enhanced Recovery After Surgery (ERAS) protocols were introduced as a method to optimize perioperative patient care. Narcotic medications are frequently utilized in postoperative care, but these have risks including sedation or dependence. Non-pharmacologic measures for postoperative pain control may help limit the need for opioids in postoperative pain control.

Early mobilization is also important after surgery, however postoperative mobility is rarely monitored and relies on subjective reports.

The investigators will seek to examine the implementation of an ERAS protocol using VR and Fitbit wearable activity devices on postoperative recovery after head and neck surgery. This is a prospective, 4-arm, randomized controlled trial.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 89 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •English speaking
  • •18 to 89 years of age.
  • •Planned to undergo major head and neck surgery OHSU with an expected length of stay of two days or more.
  • •Ability to understand goals of the study and willingness to sign a written informed consent document.

排除标准

  • •Planned postoperative admission to the intensive care unit (ICU).
  • •Social or psychiatric conditions that may interfere with compliance.
  • •Isolation precautions.
  • •Reconstruction, incisions, wounds, wound care, or injury that impact the ability to place on the VR headset or wear a Fitbit device around the wrist.
  • •History of seizure or epilepsy.
  • •History of vertigo or persistent dizziness.
  • •Limitations that impair mobility.
  • •Use of a walker or wheelchair at baseline.

研究组 & 干预措施

VR Only

Active Comparator

Daily VR only. Daily VR use every 3 hours up to 30 minutes at a time.

干预措施: Virtual Reality (Device)

VR and Fitbit

Active Comparator

Daily VR use every 3 hours up to 30 minutes at a time and Fitbit daily step goal of 2,000 steps

干预措施: Virtual Reality (Device)

VR and Fitbit

Active Comparator

Daily VR use every 3 hours up to 30 minutes at a time and Fitbit daily step goal of 2,000 steps

干预措施: Fitbit (Device)

Fitbit Only

Active Comparator

Fitbit daily step goal of 2,000 steps.

干预措施: Fitbit (Device)

Control

No Intervention

Standard of care

结局指标

主要结局

Mean daily opioid use

时间窗: through study completion, an average of 10 days

Mean daily opioid use will be assessed converted into milligram morphine equivalents (MME).

次要结局

  • Depression(Before surgery and at study completion, an average of 10 days)
  • Pain scores(through study completion, an average of 10 days)
  • Length of hospital stay(at study completion, an average of 10 days)
  • Anxiety(Before surgery and at study completion, an average of 10 days)
  • Patient experience and satisfaction(at study completion, an average of 10 days)
  • Sleep Quality(Before surgery and at study completion, an average of 10 days)
  • Disposition on discharge(at study completion, an average of 10 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ryan Li, MD

Principal Investigator

Oregon Health and Science University

研究点 (1)

Loading locations...

相似试验